https://health-union.com/wp-content/uploads/2019/11/Loneliness-and-Health-Whats-the-Social-MediaConnection.jpg
						560
						1800
				
				
						Lina Kirby
						
							https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
						
				Lina Kirby2019-04-16 13:09:422020-04-09 11:42:59Loneliness and Health: What’s the (Social Media) Connection?Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
				
						https://health-union.com/wp-content/uploads/2019/11/Loneliness-and-Health-Whats-the-Social-MediaConnection.jpg
						560
						1800
				
				
						Lina Kirby
						
							https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
						
				Lina Kirby2019-04-16 13:09:422020-04-09 11:42:59Loneliness and Health: What’s the (Social Media) Connection?
The Online Health Community Model: Role and Importance in Marketing Research

Health Union Announces Acceptance to Present at NCCN Annual Conference 2019

Health Union Announces Multiple Poster Presentations at the 40th Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine
WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities
Download the full free whitepaper, “#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities”
Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap
There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.
Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease
A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.
What People Fear the Most About Their Future With Asthma
“Asthma In America 2018” asked questions about diagnosis, medications, treatments and more to over 800 respondents. Surprisingly, the survey revealed four things people with asthma fear most about their future, all of which have a profound impact on the way they view their condition and rate their quality of life.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Your Privacy Choices ![]()
Join Our Team
Press Kit




